Jennifer Keller,Laurence P Diggs,Eddy C Hsueh
Jennifer Keller
Immune checkpoint inhibitors in the treatment of advanced mucosal melanoma [0.03%]
免疫检查点抑制剂在黏膜黑色素瘤治疗中的应用
James C Kuo
James C Kuo
Immunotherapy with immune checkpoint inhibitors is the standard of care in the treatment of advanced melanoma. Treatment outcome of these agents is less defined for the rare subtype of mucosal melanoma. In this single-institutional case ser...
Case Reports
Melanoma management. 2017 Sep;4(3):161-167. DOI:10.2217/mmt-2017-0014 2017
Thomas J Sharpe
Thomas J Sharpe
T.J. Sharpe speaks to Sebastian Dennis-Beron, Commissioning Editor: T.J. Sharpe is a stage IV melanoma patient who shares his journey through cancer in the Patient #1 Blog [1]. He was diagnosed in August 2012 with melanoma tumors in multipl...
Anti-PD-1 monotherapy versus anti-PD1 plus anti-CTLA4 in advanced melanoma: how do we decide? [0.03%]
抗PD-1单药治疗与抗PD-1和抗CTLA-4联合治疗晚期黑色素瘤：如何选择？
Lewis Au,Aine O&#x;Reilly,James Larkin
Lewis Au
Advantages of whole-genome sequencing for identification of tumor etiology and clinically actionable genomic aberrations: lessons from the Australian Melanoma Genome Project [0.03%]
全基因组测序在鉴定肿瘤病因及具有临床干预价值的基因组异常方面优势初显——来自澳大利亚黑色素瘤基因组计划项目的启示
James S Wilmott,Nicholas K Hayward,Graham J Mann et al.
James S Wilmott et al.
Utility of ipilimumab in melanoma patients who progress on anti-PD-1 therapy [0.03%]
伊匹单抗治疗接受抗PD-1治疗后病情进展的黑色素瘤患者中的疗效分析
Cesar E Ochoa,Richard W Joseph
Cesar E Ochoa
Riccardo Pampena,Caterina Longo
Riccardo Pampena
Avinash Gupta,Fabio Gomes,Paul Lorigan
Avinash Gupta
The treatment of malignant melanoma has changed beyond recognition in the last 7 years. Where previously single agent dacarbazine was often the only treatment used for advanced disease, now there are potentially multiple lines of treatment,...
Maressa C Criscito,Jennifer A Stein
Maressa C Criscito
Melanocytic lesions of acral sites are common, with an estimated prevalence of 28-36% in the USA. While the majority of these lesions are benign, differentiation from acral melanoma (AM) is often challenging. AM is a unique subtype of melan...
Brian D Wernick,Neha Goel,Francis Sw Zih et al.
Brian D Wernick et al.
Management of melanoma includes wide excision with adequate margins and lymph node biopsy depending on the depth of the lesion, with subsequent completion lymphadenectomy for positive sentinel node. Locally advanced disease can be approache...